Newfound Research’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $81K | Buy |
117
+3
| +3% | +$2.08K | 0.2% | 44 |
|
|
2022
Q2 | $67K | Sell |
114
-82
| -42% | -$48.2K | 0.14% | 102 |
|
|
2022
Q1 | $137K | Buy |
196
+36
| +23% | +$25.2K | 0.18% | 58 |
|
|
2021
Q4 | $101K | Sell |
160
-10
| -6% | -$6.31K | 0.12% | 93 |
|
|
2021
Q3 | $103K | Buy |
170
+2
| +1% | +$1.21K | 0.17% | 67 |
|
|
2021
Q2 | $94K | Buy |
168
+16
| +11% | +$8.95K | 0.19% | 26 |
|
|
2021
Q1 | $72K | Buy |
+152
| New | +$72K | 0.17% | 72 |
|
|
2020
Q4 | – | Sell |
-50
| Closed | -$28K | – | 152 |
|
|
2020
Q3 | $28K | Buy |
+50
| New | +$28K | 0.08% | 98 |
|